Clinical trial
Aurograb and Vancomycin in MRSA Infection
NCT00217841 · NeuTec Pharma, Industry · Completed
Key facts
| NCT number | NCT00217841 |
|---|---|
| Title | Aurograb and Vancomycin in MRSA Infection |
| Official title | A Multi Centre, Double-Blind, Randomised, Placebo Controlled Prospective Study on the Safety and Efficacy of Aurograb in Patients With Severe, Deep-Seated Staphylococcal Infections Receiving Vancomycin |
| Lead sponsor | NeuTec Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Staphylococcal Infections |
| Intervention type | Drug |
| Interventions | Aurograb |
| Enrollment | 180 |
| Start date | Jan 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 19, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: